We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




European Cardiac Rhythm Management Market Experiences Growth

By HospiMedica International staff writers
Posted on 09 Jun 2009
Print article
Implantable cardiac resynchronization therapy devices, advanced technologies such as ablation catheters, and the cost benefits accrued to individual national healthcare systems are invigorating the expansion of the cardiac rhythm management (CRM) market in Western Europe. These are the latest findings of Frost and Sullivan (Palo Alto, CA, USA), an international consulting firm.

The CRM market consists of a select few market participants, trying to sell high-cost, life-saving devices. Each manufacturer utilizes bipolar leads, biventricular pacing devices, high rate-adaptive pacing devices, and sophisticated algorithms to capture and translate the captured data, and the price difference between these devices is fairly marginal. Thus, the inability of niche participants to distinguish themselves is a characteristic of the market, and without product differentiation, they have been unable to capture the attention of consumers. Another concern, especially for end users, is device mortality; and battery life is one of the key factors that contribute to device longevity. Trends related to thin-film battery technology and high-energy batteries are positive, auguring well for future market prospects, but this demands an even greater focus on developing the durability of batteries, as well as other factors that contribute to device longevity. Moreover, CRM device manufacturers should continually monitor the market and steadily invest in research and development to promote product innovation and differentiation.

"Each manufacturer strives to introduce their own device features and innovations to differentiate their devices; it essentially amounts to how these devices are perceived in the mind of specialists,” said Frost & Sullivan research associate Sreevidhya Praveen. "It is critical for companies to brand their technology and establish themselves in the minds of consumers.”

"To position a company for future growth, building an effective channel to profitably distribute lower cost equipment to new, emerging users is absolutely essential,” added Mr. Praveen. "At the same time, international manufacturers should aim to establish alliances with smaller participants for the sale and distribution of their products.”

The major segments of the CRM market are achieving rapid penetration, indicative of a flourishing space for new devices, and the industry reveals natural, organic growth with all market participants set to make revenue gains. Frost and Sullivan have found that the European CRM market earned revenues of U.S. $3.4 billion in 2008 and is estimated to reach $7.3 billion in 2015.

Related Links:

Frost and Sullivan



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Hospital Bed
Alphalite
New
In-Bed Scale
IBFL500

Print article

Channels

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.